Command

Quick links to important sections

Command

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Command

Quick Facts

Property Description
Active ingredient Triflumuron
Form Suspension Concentrate (SC), Pour-on
Pharmacological class Insect Growth Regulator (IGR), Ectoparasiticide
Common use Control of external parasite infestations
Origin Synthetic benzoylurea compound

Defining Command: Classification and Identity of the Active Agent

Command is a specialized veterinary medicine defined by its single active ingredient, Triflumuron. It is classified pharmacologically as an Insect Growth Regulator (IGR), specifically belonging to the benzoylurea chemical family. Triflumuron is a synthetic compound within this class.

The product's function is rooted in its active compound, Triflumuron, which is engineered to target the life cycle of external parasites, primarily affecting livestock such as sheep and poultry. Its classification as an IGR means it operates differently from traditional adulticides, focusing on controlling the development of the pest population. The compound acts as a long-acting disruptor of parasite growth.

The Physical Form of Command and its General Purpose

Command is typically supplied as a Suspension Concentrate (SC) or formulated as a Pour-on liquid, which facilitates a topical route of administration onto the animal's coat or skin. This physical form is chosen to maximize contact with ectoparasites.

The standardized form ensures the active ingredient is delivered externally where the parasites reside. The general purpose of this targeted approach is the control and management of parasitic infestations, contributing to the health and well-being of the target animal groups by preventing the completion of the parasite life cycle. The utility of benzoylurea compounds is associated with their effective non-systemic delivery in topical forms like pour-ons. This formulation type is crucial for the effective external control of these parasites.

How Triflumuron Controls Parasites at a High Level

Triflumuron controls parasites through a precise functional principle, acting as a highly specific chitin synthesis inhibitor to achieve developmental arrest in the young parasite stages. This mechanism ensures that the parasite cannot successfully complete its life cycle and molt into its next stage.

The substance specifically blocks the formation of chitin, which is the essential structural component that forms the parasite's rigid outer shell or exoskeleton. By interfering with this vital biological process, Command prevents the young, vulnerable parasites from maturing, thereby offering a targeted, non-systemic approach for effective ectoparasite management.

What side effects are possible with Command?

Official Safety Profile and Adverse Reaction Classification

The safety profile of the active ingredient, Triflumuron, is defined primarily through its mandatory regulatory hazard classifications rather than a typical clinical frequency framework (such as common, uncommon, or rare). These classifications are established by governmental bodies to communicate the product's intrinsic toxicological properties and potential adverse characteristics.

System-Organ Classes and Local Effects

The official safety data identifies potential local and systemic effects classified by target organ systems. Local effects are primarily categorized as potential irritants to the Eye (Ocular System) and the Skin (Integumentary System). The product is officially classified as a Serious Eye Irritant and a potential Skin Sensitizer.

Serious Adverse Reactions and Systemic Risk

High-tier safety classifications documented in regulatory sources address severe, systemic hazards. These include classification for Carcinogenicity, which establishes the potential to cause cancer. Furthermore, the profile includes the risk of damage to organs (specifically the Blood and Hematopoietic System) when exposure is associated with prolonged or repeated contact. This latter finding is an official safety pattern tied to the duration of exposure.

Safety assessments note that the mechanism of action, as a chitin synthesis inhibitor, targets a system not present in mammals, suggesting the active constituent itself has low systemic toxicity in non-target species. However, the official hazard classification mandates specific restrictions on handling due to the established irritancy and high-tier systemic hazard potential.

Overdose and Emergency Response

Overdose Manifestations and When to Seek Help

The official regulatory profile for Command (Triflumuron) outlines specific hazards and strictly mandated emergency procedures for overexposure.


Documented Manifestations and Severe Outcomes

Regulatory documentation notes that non-severe human overexposure may result in no symptoms known or expected. However, the substance is classified with a severe, explicit hazard, defined as fatal if inhaled. Dermal contact carries the documented risk of an allergic skin reaction, and absorption through damaged skin may lead to systemic injury.


Required Emergency Actions and Treatment

Immediate medical attention is required for any suspected overexposure. Regulatory guidelines strictly mandate that individuals call a physician or poison control center immediately.

Management is defined as symptomatic and supportive treatment because no specific antidote is available for Triflumuron. In cases of confirmed or significant ingestion, the protocol strictly instructs individuals to DO NOT induce vomiting. Clinical procedures advised for supportive care include the potential consideration of gastric lavage and the administration of activated charcoal and sodium sulphate within the first two hours to manage potential toxicity.

Therapeutic Uses of Command

Command is applied in veterinary medicine for the management of widespread external parasite infestations in livestock. It is commonly used to help with the management of certain parasitic conditions, including lice infestations and is applied in contexts marked by increased discomfort or tension, such as the risk of blowfly strike (myiasis) in susceptible hosts. The approach is applied across therapeutic domains where additional symptomatic support is needed to reduce the overall parasitic burden and the potential for re-infestation.

The use of this product supports easing the symptoms related to parasitic activity. It helps manage the intense pruritus (itching) and skin irritation associated with louse loads. The goal is to support general well-being during symptomatic phases. By addressing the risk of myiasis and supporting the management of chronic parasitic stress, the treatment contributes to easing the physiological strain. This supports general well-being during symptomatic phases and helps manage the symptoms that interfere with daily functioning, such as normal grazing and resting patterns.


Quick Fact: Relief for Dermatological Stress

This product is commonly used when symptoms cluster into patterns requiring supportive management, such as those related to pruritus and skin irritation caused by biting ectoparasites.

Eligibility and Restrictions for Use

Command (Triflumuron) is a specialized veterinary medicine and its eligibility is strictly defined by government regulatory requirements for livestock, primarily sheep.

Eligibility Scope

Category Official Regulatory Statement
Populations for whom use is allowed Shorn sheep (up to 7 days off-shears) and unshorn lambs (up to 3 months of age) are the standard eligible populations.
Populations for whom use is contraindicated Humans (absolute contraindication; for animal use only).
Female sheep producing, or that may produce, milk for human consumption.
Target animals with known hypersensitivity to the active ingredient, Triflumuron.
Age-related eligibility rules Use is limited to lambs that meet specific minimum weight or age requirements as detailed on the official label.
Pregnancy and lactation eligibility status Lactation is prohibited if milk or milk products are intended for human consumption.
Pregnant ewes are generally permitted for treatment, but labeling must be checked for any specific conditions.
Eligibility-related restrictions Treated animals become temporarily ineligible for the human food chain until the mandated Meat Withholding Period and/or Export Slaughter Interval has elapsed.

Eligibility Classifications (High-Level)

Official regulatory documents classify use as Absolute Contraindication for humans and milk-producing animals. The primary constraint is Food Chain Compliance, which governs when treated animals are eligible for slaughter. Eligibility is also contingent on the animal's physical state, such as its shorn status.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The official regulatory profile for Command (Triflumuron), a topical veterinary Insect Growth Regulator (IGR), defines interaction rules primarily based on co-administration for efficacy and administration restrictions for environmental safety, rather than systemic drug-drug interactions.

Interaction Classification and Constraints

Category Regulatory Statement
Pharmacodynamic Compatibility Co-administration through tank mixing with specific adulticides is officially compatible to achieve rapid pest control.
Efficacy Restriction Repeated use with other Group 15A Insecticides may reduce the product's effectiveness against resistant insect biotypes; this is an interaction-related constraint on sequential product use.
Contamination Restriction Mandatory avoidance of contact with food, feedstuffs, and preparation areas, requiring the removal or covering of exposed items before application.
Contraindications No substance is explicitly prohibited for co-administration due to systemic biological interaction risk.

No systemic pharmacokinetic interactions, such as those mediated by CYP enzymes or drug transporters, are documented in the official regulatory labeling for this product. The official statements exclusively detail substance compatibilities and mandated administration constraints to maintain product efficacy and prevent environmental contact with feed sources.

Mechanism of Action

Targeted Inhibition of Chitin Synthesis

The mechanism of action centers on the specific enzymatic inhibition of Chitin Synthase 1 (CHS1), a core enzyme essential for creating chitin, the main structural polymer of the parasite's exoskeleton. This action prevents the proper formation of the outer shell (cuticle), which is an exclusive biochemical process of arthropods.

Disruption of the Molting Cycle

By blocking the synthesis of new chitin, the drug critically disrupts the Arthropod Molting Cycle (Ecdysis). This failure leads to the inability of the developing parasite (larva or nymph) to successfully complete ecdysis. The consequence is developmental arrest and physiological collapse due to compromised structural integrity. The physiological consequence is realized only at the point the parasite attempts its next scheduled molt.

Stage-Specific Mechanistic Constraint

The mechanism is intrinsically limited by stage-specificity, as its action is functionally constrained to actively growing and molting parasite stages. Consequently, the mechanism is generally ineffective against non-molting adult parasites, dictating a mechanism that interferes with the reproductive capacity and growth of the pest population, rather than exhibiting immediate neurotoxic effects on mature pests.

Dosage and Administration Information

Administration Scope and Principles

Command (Triflumuron) is administered via the topical route using the Pour-on application method. The protocol for use involves a single application treatment, meaning the medicine is applied once for the management of external parasites.

Standardized Dosing Principles

The required dose volume is volumetric and determined by the animal's liveweight. To ensure adequate coverage across the entire group, the dosing regimen involves calculating the volume based on the weight of the heaviest animal in the treated mob, and this volume is then applied to all animals. This calculated volume is aligned with the product's dosing scale.

Feature Instruction Principle
Application Window Applied to shorn sheep within seven days off-shears.
Application Site A single, continuous strip along the backline, from the poll to the base of the tail.
Special Conditions Efficacy is not reduced by moderate rainfall occurring within four days of treatment.

Population and Procedural Rules

Procedural principles involve treating all animals in the flock concurrently. Specific adjustments for young animals allow unshorn lambs or kids to be treated, provided they are under three months of age. This single treatment is intended to provide protection against the re-establishment of parasite populations for up to twelve weeks, establishing a defined usage cycle.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Command

Evidence for Use in External Parasite Control

Research into Command, which contains the active ingredient Triflumuron, is founded on pharmacological studies that evaluated it as an Insect Growth Regulator (IGR). These studies explored how the synthetic compound was studied for the management of external parasites. The evidence was studied for its functional principle, which involves preventing young parasites from maturing and completing their life cycle. Studies monitored the compound's effectiveness as a long-acting disruptor, focusing on whether it is associated with a disruption of development. Reviews also examined the effective, non-systemic delivery that was observed in topical forms like pour-ons.

Evidence for Management of Specific Parasitic Conditions

The use of Command was studied for the management of specific parasitic conditions in livestock. This evidence was evaluated in the context of data from authoritative sources, such as regulatory product searches. This research examined the product's inclusion in management strategies for conditions like lice infestations. The data describe the product's place in management contexts that address the overall parasitic burden. Similarly, research examined its inclusion in management contexts that address the overall parasitic burden in contexts marked by the risk of blowfly strike (myiasis).

Research on Symptomatic Support During Parasitic Activity

Command was studied for its application within the therapeutic domain focusing on supportive management during periods of heightened symptom activity. This research explores how symptoms evolved in populations experiencing pruritus (itching) and skin irritation. The evidence was studied for its inclusion in contexts where the research goal was related to outcomes tied to physical discomfort. Formal studies specifically measuring and reporting changes in patient-reported outcomes describing perceived discomfort as primary, quantifiable research endpoints are not fully established in the available summaries, thus certainty remains low for these high-level symptomatic outcomes.

What the Research Still Needs to Clarify

Research has explored short-term symptom changes, but follow-up durations were limited, meaning long-term effects are not fully established. Comparative evidence against other standard therapies is also lacking in the provided summaries. The data for certain groups of susceptible hosts remain insufficient to draw broad conclusions, and evidence quality varies across studies.

Key Studies & References Triflumuron (Ref: OMS 2015) - AERU - University of Hertfordshire (For IGR mode of action and specific product formulation details, including pour-ons)

Frequently Asked Questions (FAQ)

Common questions about Command (FAQ)


Q: Is Command a new type of medication or has it been around a while?

A: Command’s active ingredient, Triflumuron, belongs to the benzoylurea chemical class of Insect Growth Regulators (IGRs), a chemical group that was first identified in the 1970s. The pharmacological studies supporting its use have been widely supported across the veterinary field.


Q: How long does it usually take for Command to start working?

A: According to official product information, the product’s effect is not immediate. Because it works by disrupting the parasite’s molting cycle, the consequence of the drug is realized only when the parasite attempts its next scheduled molt.


Q: Is it normal to feel tired after taking Command?

A: Command is a specialized veterinary medicine that operates by targeting the synthesis of chitin, a biological system absent in mammals. The official safety profile for the product does not include tiredness or lethargy as a specific adverse reaction.


Q: Can Command be used by people with kidney issues?

A: Official regulatory documents define Command as a specialized veterinary product for livestock. Its use is classified as an absolute contraindication for human beings, regardless of any underlying health condition.


Q: Will Command show up on a standard drug test?

A: As a veterinary product, Command’s use is managed under food chain compliance rules. This includes a mandated Meat Withholding Period and Export Slaughter Interval to ensure residues clear before the treated animals are eligible for the human food chain.


Q: Does Command lose effectiveness over time?

A: The product is designed to provide protection for up to twelve weeks following a single application. However, regulatory warnings note that repeated use with other specific Group 15A Insecticides may reduce its long-term effectiveness due to the risk of resistance.


Q: Why does the official information mention a risk of [Rare Side Effect]?

A: Official regulatory information communicates the product’s toxicological properties through hazard classifications, such as Serious Eye Irritant or Carcinogenicity. These classifications communicate potential intrinsic risk and mandated handling precautions, but they do not represent the frequency of clinical occurrence in the target animal population.


Q: Is Command addictive or habit-forming?

A: The active ingredient in Command, Triflumuron, is classified as an insecticide and is not listed as a controlled substance in US regulatory schedules. It is not considered to be addictive or habit-forming.


Q: What kind of studies have been done on Command in different patient populations?

A: Research evidence focused on the product's use for external parasite control in specific livestock populations. Studies were conducted consistent with its approved eligibility scope, primarily focusing on shorn sheep and unshorn lambs.


Q: Are there any restrictions on alcohol consumption while using Command?

A: The official regulatory profile for this non-systemic, topical veterinary product is centered on co-administration compatibilities and contamination restrictions. It does not document any systemic interaction with substances like alcohol.


Q: What is the purpose of the different inactive ingredients in Command?

A: The product is supplied as a Suspension Concentrate or Pour-on, which requires a specific formulation. Inactive ingredients are necessary to aid in product stability, act as a carrier, and maximize the product's effective topical contact with the ectoparasites.


Q: How is the eligibility criteria for Command defined in official sources?

A: Official sources define eligibility through high-level classifications. These include an Absolute Contraindication for humans and milk-producing animals, and restrictions contingent on Food Chain Compliance and the target animal’s physical state, such as its shorn status.


Q: Can Command be taken with common over-the-counter pain relievers?

A: Command is classified by regulatory documents as a specialized veterinary product for livestock. Its use is an absolute contraindication for human beings, which means it is not to be consumed with any medications, including common over-the-counter pain relievers.


Q: Can Command affect my ability to drive or operate machinery?

A: Command is classified as a specialized veterinary product for livestock. Official regulatory documents list its use as an absolute contraindication for human beings.


Q: What happens if I forget to take a dose of Command?

A: The official protocol specifies the use of Command as a single application treatment only. The product is not designed for a daily regimen, and therefore the treatment instructions do not include managing a missed dose.


Q: Is Command safe for long-term use?

A: Research summaries indicate that the follow-up durations for studies were limited. Therefore, the long-term effects of the product's use are not fully established in the available evidence.


Q: Is Command suitable for people with liver disease?

A: Official regulatory documents classify the use of Command as an absolute contraindication for human beings, regardless of any underlying health condition. It is a specialized veterinary product for livestock.


Q: Are there any known interactions between Command and herbal supplements?

A: The official regulatory profile for this non-systemic, topical product focuses on co-administration with other insecticides and feedstuff contamination. It does not document any systemic interaction with herbal supplements.


Q: What happens if I accidentally take two doses of Command close together?

A: The product is designed for a single application treatment only. The official instructions do not provide specific guidance for managing an accidental re-dose or overdose.


Q: Can I stop taking Command suddenly, or does it need to be tapered?

A: The official protocol specifies the use of Command as a single application treatment only. The product is not part of a continuous regimen and therefore does not require discontinuation management or tapering.


Q: Is Command often prescribed alongside other medications for the same condition?

A: Co-administration through tank mixing with specific adulticides is officially compatible according to the regulatory profile. This is done to achieve rapid pest control in addition to Command’s developmental disruption.


Q: Does Command affect mood or energy levels?

A: Command is a specialized veterinary medicine that targets a biological system that is absent in mammals. Its official safety profile does not include effects on mood or energy levels as specific adverse reactions.


Q: Is it true that Command is not recommended during pregnancy?

A: Official labeling generally permits the treatment of pregnant ewes. However, the label should be reviewed for any specific conditions or limitations on use during pregnancy.


Q: Has Command been studied in pediatric patients?

A: The eligibility rules and research focused on unshorn lambs or kids under three months of age. This represents the youngest eligible population for which the product is approved for use.


Q: Is there an official patient information leaflet for Command online?

A: Official product information, such as the full regulatory label or the Summary of Product Characteristics (SmPC), is published by governmental regulatory bodies. These documents serve as the definitive, publicly available source of product details.


Q: Can Command affect my sleep schedule?

A: Command is classified as a specialized veterinary product for livestock. Official regulatory documents list its use as an absolute contraindication for human beings.


Q: Are there any specific lifestyle changes recommended when starting Command?

A: Official procedural rules mandate specific physical conditions for use, such as application to shorn sheep within seven days off-shears. These are mandatory administration requirements, not general lifestyle recommendations.


Q: What should I know about the long-term research on Command's safety?

A: Research summaries indicate that follow-up durations were limited in the available studies. Therefore, the full long-term safety effects of the product’s use are not fully established in the available evidence.


Q: Does Command interact with commonly used cold and flu medications?

A: Command is classified by regulatory documents as a specialized veterinary product for livestock. Its use is an absolute contraindication for human beings, which means it is not to be consumed with any medications.


Q: Is Command known to cause any interactions with caffeine?

A: Command is classified by regulatory documents as a specialized veterinary product for livestock. Its use is an absolute contraindication for human beings.


Q: What is the difference between Command tablets and capsules (if applicable)?

A: Command is officially supplied as a Suspension Concentrate or formulated as a Pour-on liquid. Tablets or capsules are not listed as approved physical forms in the official documentation.


Q: Are there different forms of Command available (e.g., liquid, injectable)?

A: Command is officially supplied as a Suspension Concentrate or formulated as a Pour-on liquid, which are both external liquid forms. The official documentation does not list an injectable form of the product.

How should Command be stored and disposed of?

How to Store and Dispose of Command 3ME Herbicide

Official regulations require Command 3ME to be stored in a cool, dry, and well-ventilated location, strictly above -4 F (–20 C) to prevent freezing, and away from heat or open flames. The product must be kept out of reach of children and animals in a locked area. The container must remain tightly closed in its original packaging; opened containers must be carefully resealed to prevent leakage.

Disposal instructions mandate that all unused product, rinsate, and equipment washwaters must be managed in accordance with local and national regulations. To protect the environment, it is strictly required to prevent the product from entering drains, watercourses, or sewers.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Command found in:

A-Z Index: